1
|
Frey SM, Clerc OF, Honegger U, Amrein M, Thommen K, Caobelli F, Haaf P, Müller CE, Zellweger MJ. The power of zero calcium in 82-Rubidium PET irrespective of sex and age. J Nucl Cardiol 2023; 30:1514-1527. [PMID: 36624363 PMCID: PMC10371904 DOI: 10.1007/s12350-022-03174-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2022] [Accepted: 11/16/2022] [Indexed: 01/11/2023]
Abstract
BACKGROUND Despite clinical suspicion, many non-invasive tests for coronary artery disease (CAD) are normal. Coronary artery calcification score (CACS) is a well-validated method to detect and risk stratify CAD. Patients with zero calcium score (ZCS) rarely have abnormal tests. Therefore, aims were to evaluate CACS as a gatekeeper to further functional downstream testing for CAD and estimate potential radiation and cost savings. METHODS Consecutive patients with suspected CAD referred for PET were included (n = 2640). Prevalence and test characteristics of ZCS were calculated in different groups. Summed stress score ≥ 4 was considered abnormal and summed difference score ≥ 7 equivalent to ≥ 10% ischemia. To estimate potential radiation/cost reduction, PET scans were hypothetically omitted in ZCS patients. RESULTS Mean age was 65 ± 11 years, 46% were female. 21% scans were abnormal and 26% of patients had ZCS. CACS was higher in abnormal PET (median 561 vs 27, P < 0.001). Abnormal PET was significantly less frequent in ZCS patients (2.6% vs 27.6%, P < 0.001). Sensitivity/negative predictive value (NPV) of ZCS to detect/exclude abnormal PET and ≥ 10% ischemia were 96.8% (95%-CI 95.0%-97.9%)/97.4% (95.9%-98.3%) and 98.9% (96.7%-99.6%)/99.6% (98.7%-99.9%), respectively. Radiation and cost reduction were estimated to be 23% and 22%, respectively. CONCLUSIONS ZCS is frequent, and most often consistent with normal PET scans. ZCS offers an excellent NPV to exclude an abnormal PET and ≥ 10% ischemia across different gender and age groups. CACS is a suitable gatekeeper before advanced cardiac imaging, and potential radiation/cost savings are substantial. However, further studies including safety endpoints are needed.
Collapse
Affiliation(s)
- Simon M. Frey
- Department of Cardiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland
- Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland
| | - Olivier F. Clerc
- Department of Cardiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland
- Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland
| | - Ursina Honegger
- Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland
| | - Melissa Amrein
- Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland
| | - Kathrin Thommen
- Department of Cardiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland
| | - Federico Caobelli
- Department of Radiology and Nuclear Medicine, University Hospital Basel, University of Basel, Basel, Switzerland
| | - Philip Haaf
- Department of Cardiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland
- Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland
| | - Christian E. Müller
- Department of Cardiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland
- Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland
| | - Michael J. Zellweger
- Department of Cardiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland
- Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland
| |
Collapse
|
2
|
Slim AM, Fentanes E, Cheezum MK, Parsons IT, Maroules C, Chen B, Abbara S, Branch K, Nagpal P, Shah NR, Thomas DM, Villines TC, Blankstein R, Shaw LJ, Budoff M, Nicol E. The role of cardiovascular CT in occupational health assessment for coronary heart disease: An expert consensus document from the Society of Cardiovascular Computed Tomography (SCCT). J Cardiovasc Comput Tomogr 2021; 15:290-303. [PMID: 33926854 DOI: 10.1016/j.jcct.2021.03.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
| | | | | | | | | | - Billy Chen
- Cedars-Sinai Medical Center, Baldwin Park, CA, USA
| | - Suhny Abbara
- University of Texas Southwestern Medical Center, Dallas, TX, USA
| | | | - Prashant Nagpal
- University of Iowa Hospitals and Clinics, Iowa City, IA, USA
| | - Nishant R Shah
- Brown University Warren Alpert Medical School, Providence, RI, USA
| | - Dustin M Thomas
- Parkview Health, Parkview Research Center, Fort Wayne, IN, USA
| | - Todd C Villines
- University of Virginia Health System, Charlottesville, VA, USA
| | - Ron Blankstein
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | | | | | - Ed Nicol
- Royal Brompton Hospital, London, UK
| |
Collapse
|
5
|
Patterson PD, Suyama J, Reis SE, Weaver MD, Hostler D. What does it cost to prevent on-duty firefighter cardiac events? A content valid method for calculating costs. Adv Prev Med 2013; 2013:972724. [PMID: 24455288 PMCID: PMC3881339 DOI: 10.1155/2013/972724] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2013] [Accepted: 10/29/2013] [Indexed: 11/17/2022] Open
Abstract
Cardiac arrest is a leading cause of mortality among firefighters. We sought to develop a valid method for determining the costs of a workplace prevention program for firefighters. In 2012, we developed a draft framework using human resource accounting and in-depth interviews with experts in the firefighting and insurance industries. The interviews produced a draft cost model with 6 components and 26 subcomponents. In 2013, we randomly sampled 100 fire chiefs out of >7,400 affiliated with the International Association of Fire Chiefs. We used the Content Validity Index (CVI) to identify the content valid components of the draft cost model. This was accomplished by having fire chiefs rate the relevancy of cost components using a 4-point Likert scale (highly relevant to not relevant). We received complete survey data from 65 fire chiefs (65% response rate). We retained 5 components and 21 subcomponents based on CVI scores ≥0.70. The five main components include, (1) investment costs, (2) orientation and training costs, (3) medical and pharmaceutical costs, (4) education and continuing education costs, and (5) maintenance costs. Data from a diverse sample of fire chiefs has produced a content valid method for calculating the cost of a prevention program among firefighters.
Collapse
Affiliation(s)
- P. Daniel Patterson
- University of Pittsburgh School of Medicine, Department of Emergency Medicine, 3600 Forbes Avenue, Suite 400A, Pittsburgh, PA 15261, USA
| | - Joe Suyama
- University of Pittsburgh School of Medicine, Department of Emergency Medicine, 3600 Forbes Avenue, Suite 400A, Pittsburgh, PA 15261, USA
| | - Steven E. Reis
- University of Pittsburgh School of Medicine, Department of Emergency Medicine, 3600 Forbes Avenue, Suite 400A, Pittsburgh, PA 15261, USA
| | - Matthew D. Weaver
- University of Pittsburgh School of Medicine, Department of Emergency Medicine, 3600 Forbes Avenue, Suite 400A, Pittsburgh, PA 15261, USA
| | - David Hostler
- University of Pittsburgh School of Medicine, Department of Emergency Medicine, 3600 Forbes Avenue, Suite 400A, Pittsburgh, PA 15261, USA
| |
Collapse
|
14
|
Shaw LJ, Mieres JH, Hendel RH, Boden WE, Gulati M, Veledar E, Hachamovitch R, Arrighi JA, Bairey Merz CN, Gibbons RJ, Wenger NK, Heller GV. Comparative Effectiveness of Exercise Electrocardiography With or Without Myocardial Perfusion Single Photon Emission Computed Tomography in Women With Suspected Coronary Artery Disease. Circulation 2011; 124:1239-49. [DOI: 10.1161/circulationaha.111.029660] [Citation(s) in RCA: 207] [Impact Index Per Article: 15.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background—
There is a paucity of randomized trials regarding diagnostic testing in women with suspected coronary artery disease (CAD). It remains unclear whether the addition of myocardial perfusion imaging (MPI) to the standard ECG exercise treadmill test (ETT) provides incremental information to improve clinical decision making in women with suspected CAD.
Methods and Results—
We randomized symptomatic women with suspected CAD, an interpretable ECG, and ≥5 metabolic equivalents on the Duke Activity Status Index to 1 of 2 diagnostic strategies: ETT or exercise MPI. The primary end point was 2-year incidence of major adverse cardiac events, defined as CAD death or hospitalization for an acute coronary syndrome or heart failure. A total of 824 women were randomized to ETT or exercise MPI. For women randomized to ETT, ECG results were normal in 64%, indeterminate in 16%, and abnormal in 20%. By comparison, the exercise MPI results were normal in 91%, mildly abnormal in 3%, and moderate to severely abnormal in 6%. At 2 years, there was no difference in major adverse cardiac events (98.0% for ETT and 97.7% for MPI;
P
=0.59). Compared with ETT, index testing costs were higher for exercise MPI (
P
<0.001), whereas downstream procedural costs were slightly lower (
P
=0.0008). Overall, the cumulative diagnostic cost savings was 48% for ETT compared with exercise MPI (
P
<0.001).
Conclusions—
In low-risk, exercising women, a diagnostic strategy that uses ETT versus exercise MPI yields similar 2-year posttest outcomes while providing significant diagnostic cost savings. The ETT with selective follow-up testing should be considered as the initial diagnostic strategy in symptomatic women with suspected CAD.
Clinical Trial Registration—
http://www.clinicaltrials.gov
. Unique identifier: NCT00282711.
Collapse
Affiliation(s)
- Leslee J. Shaw
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - Jennifer H. Mieres
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - Robert H. Hendel
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - William E. Boden
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - Martha Gulati
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - Emir Veledar
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - Rory Hachamovitch
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - James A. Arrighi
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - C. Noel Bairey Merz
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - Raymond J. Gibbons
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - Nanette K. Wenger
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | - Gary V. Heller
- From Emory University, Atlanta, GA (L.J.S., E.V., N.K.W.); North Shore–Long Island Jewish Hospital, Manhasset, NY (J.H.M.); University of Miami, Miami, FL (R.H.H.); University of Buffalo, Buffalo, NY (W.E.B.); Ohio State University, Columbus (M.G.); Cleveland Clinic Foundation, Cleveland, OH (R.H.); Brown University, Providence, RI (J.A.A.); Cedars-Sinai Heart Institute, Los Angeles, CA (C.N.B.M.); Mayo Clinic, Rochester, MN (R.J.G.); and Hartford Hospital, Hartford, CT (G.V.H.)
| | | |
Collapse
|